Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan H Gradman

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Clinical Drug Investigation|November 1, 2011
Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phaseDomenic Sica, Alan H Gradman, Ole Lederballe, et al.
Hypertension (Dallas, Tex. : 1979)|November 18, 2009
Aliskiren monotherapy does not cause paradoxical blood pressure rises: meta-analysis of data from 8 clinical trialsAlice V Stanton, Alan H Gradman, Roland E Schmieder, et al.
Circulation|February 23, 2005
Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patientsAlan H Gradman, Roland E Schmieder, Robert L Lins, et al.
Journal of Cardiac Failure|August 26, 2014
Is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital databaseAlan H Gradman, Francis Vekeman, Adi Eldar-Lissai, et al.
Journal of Cardiac Failure|March 23, 2015
Response to comment on "is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital database"Alan H Gradman, Francis Vekeman, Adi Eldar-Lissai, et al.
Lancet (London, England)|June 3, 2014
Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre studyThomas D Giles, Michael A Weber, Jan Basile, et al.
Journal of the American Society of Hypertension : JASH|April 20, 2010
Combination therapy in hypertensionAlan H Gradman, Jan N Basile, Barry L Carter, et al.
Journal of Managed Care & Specialty Pharmacy|November 2, 2015
A Call for Appropriate Evidence and Outcomes-Based Use and Measurement of Anticoagulation for Atrial Fibrillation: Moving the Population Towards Improved Health Via Multiple StakeholdersDavid S Kountz, Fadia T Shaya, Alan H Gradman, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Clinical Drug Investigation|November 1, 2011
Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phaseDomenic Sica, Alan H Gradman, Ole Lederballe, et al.
Hypertension (Dallas, Tex. : 1979)|November 18, 2009
Aliskiren monotherapy does not cause paradoxical blood pressure rises: meta-analysis of data from 8 clinical trialsAlice V Stanton, Alan H Gradman, Roland E Schmieder, et al.
Circulation|February 23, 2005
Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patientsAlan H Gradman, Roland E Schmieder, Robert L Lins, et al.
Journal of Cardiac Failure|August 26, 2014
Is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital databaseAlan H Gradman, Francis Vekeman, Adi Eldar-Lissai, et al.
Journal of Cardiac Failure|March 23, 2015
Response to comment on "is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital database"Alan H Gradman, Francis Vekeman, Adi Eldar-Lissai, et al.
Lancet (London, England)|June 3, 2014
Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre studyThomas D Giles, Michael A Weber, Jan Basile, et al.
Journal of the American Society of Hypertension : JASH|April 20, 2010
Combination therapy in hypertensionAlan H Gradman, Jan N Basile, Barry L Carter, et al.
Journal of Managed Care & Specialty Pharmacy|November 2, 2015
A Call for Appropriate Evidence and Outcomes-Based Use and Measurement of Anticoagulation for Atrial Fibrillation: Moving the Population Towards Improved Health Via Multiple StakeholdersDavid S Kountz, Fadia T Shaya, Alan H Gradman, et al.
Pageof 5